Mankind Pharma Ltd Annually Results

Gross Sales

12,207.44

10,260.44

8,749.43

7,781.56

6,214.43

Excise Duty

0

0

0

0

0

Net Sales

12,207.44

10,260.44

8,749.43

7,781.56

6,214.43

Other Operating Income

0

0

0

0

0

Other Income

553.56

296.41

140.99

210.48

182.63

Total Income

12,761

10,556.85

8,890.42

7,992.03

6,397.06

Total Expenditure

9,189.51

7,746.76

6,848.8

5,792.2

4,566.33

PBIDT

3,571.49

2,810.09

2,041.63

2,199.83

1,830.73

Interest

429.41

32.75

44.47

58.61

20.15

PBDT

3,142.08

2,777.34

1,997.16

2,141.22

1,810.58

Depreciation

621.22

378.42

325.92

166.62

118.97

Minority Interest Before NP

0

0

0

0

0

Tax

596.04

492.51

327.56

469.03

396.17

Deferred Tax

-86.3

-35.36

34.01

52.61

2.41

Reported Profit After Tax

2,011.12

1,941.77

1,309.68

1,452.96

1,293.03

Minority Interest After NP

20.16

28.87

27.82

19.48

27.61

Net Profit after Minority Interest

1,990.96

1,912.9

1,281.86

1,433.48

1,265.43

Extra-ordinary Items

4.53

0.98

0

0

0

Adjusted Profit After Extra-ordinary item

1,986.43

1,911.92

1,281.86

1,433.48

1,265.43

EPS (Unit Curr.)

49.28

47.75

32

35.78

32.28

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

41.26

40.06

40.06

40.06

45.06

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

29.25

27.38

23.33

28.26

29.45

PBDTM(%)

25.73

27.06

22.82

27.51

29.13

PATM(%)

16.47

18.92

14.96

18.67

20.8